News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
19-Oct-2007 - Innogenetics announced an agreement with Novartis on major licensing terms in the field of Hepatitis C Virus (HCV) diagnostics. According to the license agreement, Novartis grants Innogenetics a license to its Hepatitis C patent rights in the field of HCV immunodiagnostics in certain territories. ...
17-Oct-2007 - The Innogenetics Board of Directors has named Chief Financial Officer (CFO) Christiaan De Wilde as the company's Chief Executive Officer (CEO), following the resignation of Frank Morich to pursue other interests. Christiaan has served as CFO of Innogenetics and a member of its Management ...
15-Oct-2007 - Innogenetics NV and AdnaGen AG announced that they have entered into an exclusive worldwide license agreement to develop and commercialize new multiplex tests in the field of oncology. The diagnostic tests rely on circulating tumour cells in patients' blood. The exclusive license covers fields ...
11-Sep-2007 - Innogenetics announced the top-line results of the second placebo-controlled clinical trial with its viral protein E1-based therapeutic vaccine candidate for patients chronically infected with hepatitis C virus (HCV). The trial was designed to assess safety and efficacy. Results again confirmed ...
14-Jun-2007 - At the Alzheimer's Association's International Conference on Prevention of Dementia, Innogenetics presented research results with the first commercial blood test for beta-amyloid protein. Beta-amyloid is one of the potential biomarkers for Alzheimer's disease. With this new test, the INNO-BIA ...
26-Feb-2007 - Innogenetics and Bio-Rad Laboratories, Inc. announced that the two companies have finalized a non-exclusive licensing agreement for patents in the field of viral diagnostics. According to the terms of the non-exclusive agreement, Innogenetics will get a license from Bio-Rad that has exclusive ...
22-Dec-2006 - Innogenetics NV announced that Innogenetics has entered into a distribution agreement with Immuno-Biological Laboratories Co., Ltd. (IBL Japan). Innogenetics gains distribution rights for ELISA-based tests to determine specific forms of the beta amyloid protein, a key parameter in Alzheimer's ...
15-Nov-2006 - Sanofi-aventis, Innogenetics, and Inserm, through its subsidiary called Inserm Transfert, announced the conclusion of a collaborative research agreement in the field of Alzheimer's disease. This collaboration agreement is signed for an initial period of 2 years, with an option for Sanofi-aventis ...
07-Sep-2006 - Innogenetics announced its entry into the field of Human papillomavirus (HPV) diagnostic testing, in line with its diagnostics growth strategy. Infection with HPV genotypes 16 and 18, amongst others, is strongly associated with the development of cervical cancer. These genotypes are also present ...
05-Sep-2006 - On Friday, September 1, 2006, a Jury unanimously upheld the validity of Innogenetics' patent, U.S. Patent No. 5,846,704 ("the '704 patent"), which claims a method of genotyping the Hepatitis C Virus ("HCV"). The dispute began in September 2005 when Innogenetics brought suit against Abbott ...
© 1997-2024 LUMITOS AG, All rights reserved